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on day 0 and 7. 10 Wistar rats were used as control, with injection of
0.05M acetic acid. On day 16 all 10 CIA rats were diseased, determined
by swollen paws. All the rats were scariﬁed at day 26. Blood was taken
at baseline, during the experiment and at termination and used for
biomarkers measurements. Disease onset was deﬁned as the day with
signiﬁcant difference between the paw score (swelling of paws) of SHAM
and CIA. ELISAs were used to quantitatively measure turnover of type III
collagen, CO3–610 to detect degradation and PIIINP to detect formation.
A novel competitive ELISA (s-NysCo3) was used to detect nitrosylation
of mature type III collagen.
Results: A 40% increase in degradation of type III collagen was detected
in CIA rats after disease onset, but no signiﬁcant increase in formation
of type III collagen was detected. However, there was a tendency of
increased formation of type III collagen in CIA rats after disease onset.
These results led to a 40% increase of type III collagen turnover in the
diseased CIA rats and this increase of turnover was already, though not
signiﬁcant, detected at day 7. The nitrosylation of mature type III collagen
was detected with at novel competitive ELISA, showing a tendency of
increased nitrosylation of type III collagen in CIA rats after disease onset.
However, when comparing the amount of nitrosylation to the amount of
degraded type III collagen, a decrease in nitrosylation of type III collagen
was detected.
Conclusions: Collagen induced arthritis in rats increased type III collagen
turnover after disease onset and the level of nitrosylation of tyrosines
was elevated compared to SHAM. However, the level of nitrosylation in
CIA rats compared to the turnover of type III collagen showed lower a
nitrosylation rate. This could be a direct effect of the increased amount
of degradation of type III collagen in the CIA rats. In conclusion, the level
nitrosylation of type III collagen is depended of the turnover of type III
collagen.
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INHIBITION OF TRANSFORMING GROWTH FACTOR ALPHA SIGNALING
SLOWS PROGRESSION OF OSTEOARTHRITIS
S.E. Usmani, T.C. Appleton, V. Ulici, I.D. Welch, T.L. Hill, F. Beier. The Univ.
of Western Ontario, London, ON, Canada
Purpose: No cures currently exist for the degenerative joint disease
osteoarthritis (OA). Furthermore, the complex and multi-variable nature
of OA continues to challenge the development of effective therapies. In an
attempt to identify potential targets for disease modifying osteoarthritis
drugs (DMOADs), our lab recently established a surgical model of OA to
study gene expression changes in degenerating cartilage. Transforming
growth factor alpha (TGFa) gene expression was upregulated in our
model and further in vitro studies showed that TGFa suppressed
chondrocyte expression of anabolic factors aggrecan and type II collagen
and increased expression of the catabolic factor matrix metalloproteinase
13 (MMP13). We thus identiﬁed TGFa as a novel therapeutic OA target.
The purpose of this project is to examine the role of TGFa in the
development of OA in vivo. We hypothesize that inhibition of TGFa
signaling will delay disease progression in surgical OA models.
Methods: Adult male Tgfa null mice and control littermates received
either meniscotibial transection (MTX) or sham surgery. At 7 and
14 weeks post-surgery knee joint histopathology was assessed using
the OARSI scoring method and tissues were immunostained for disease
markers such as MMP13 and type II collagen neoepitopes. Since
some features of cartilage and bone development are known to be
recapitulated during the disease process, skeletal development in Tgfa
null mice was also examined.
Results: MTX surgery produced mild and moderate OA in mice after 7
and 14 weeks. Tgfa null mice had lower OARSI scores and expressed less
MMP13 and type II collagen neoepitopes than their control littermates.
Tgfa null mice also showed transient growth retardation after birth.
Histological analyses demonstrated a wider hypertrophic zone of the
growth plate. TRAP staining showed a decrease in osteoclasts at
the cartilage-bone interface, suggesting that removal of hypertrophic
cartilage is delayed. These phenotypes are absent in adult mice.
Conclusions: TGFa signaling plays an important role in osteoarthritis
progression in vivo and should be investigated further as a potential
target for DMOAD development.
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Purpose: Intra-articular injection of monoiodoacetate (MIA) in the
rodent joint can cause chondrocyte death and subsequent cartilage
degeneration. It can also lead to subchondral bone degradation and
gait alteration. Therefore it is considered a useful osteoarthritis model to
evaluate pharmaceutical and biologic agents to inhibit cartilage and bone
degeneration and alleviate pain. The severity of pain/gait alteration and
structural damage depend on MIA concentration and injection frequency.
However it is unknown if there is any correlation between pain and
structural damage over time. This study investigates how the pain/gait
change correlates with structural damages longitudinally at two MIA
doses in rat. It was hypothesized that the gait and structural changes
would exhibit a similar trend during the post-MIA injection period.
Methods: Two groups of Sprague Dawley rats (n = 12/group) were
injected with 0.5mg or 2mg of MIA (40ml) on day 0 on their right knees.
Gait analysis, incapacitance testing, and knee diameter measurement
were performed before MIA injection and on days 3, 7, 14, 21, 28, and
35 days post-injection. Animals were sacriﬁced on days 21 (n =4) and 35
(n =8) for microCT and histopathologic evaluation. For microCT, the right
knee from each animal was scanned at a norminal resolution of 18mm
using Scanco mCT80. Bone volume of distal condyles was determined.
For histopathology, the right knees were trimmed into two equal frontal
halves, ﬁxed, decalciﬁed, embedded in parafﬁn and sectioned. Sctions
were stained with toluidine blue and examined microscopically. Cartilage
matrix damage, bone resorption, bone sclerosis and osteophyte were
scored for each sample. All data were expressed as Mean±SD. Two-way
ANOVA and post-hoc Tukey’s HSD testing or non-parametric testing were
performed with P < 0.05 considered signiﬁcant.
Fig. 1. Deﬁciency of right to total hindleg weight distribution by
incapacitance test.
Fig. 2. Representative microCT images of distal femur.
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Fig. 3. Cartilage matrix damage scores with higher score indicating more
damage.
Results: All animals exhibited a more painful joint on day 3 post-
injection compared to day 0 (Fig. 1). Higher MIA dose caused more
pain and greater gait alteration than the lower dose after day 7 with
one exception. There was no difference on weight distribution between
the two doses on day 35. Animals injected with 2mg MIA had larger
knee diameter than those with 0.5mg MIA. Bone volume (Fig. 2) was
signiﬁcantly lower in animals injected with high dose of MIA. However,
bone volume in both groups increased from day 21 to day 35 regardless of
MIA dose. The high MIA dose caused signiﬁcantly more severe cartilage
matrix damage (Fig. 3), bone resorption and osteophyte formation on
day 21, which did not worsen further by day 35. In the low MIA injection
group, severity of joint damage increased from day 21 to day 35, resulting
in similar levels of damage for both groups by day 35. The subchondral
bone sclerosis was worse in lower dose group than the higher one on
both days.
Conclusions: In this study, we evaluated the temporal effect of MIA dose
on joint pain and structural damages using an established rat model.
The results demonstrated that the higher MIA dose caused more severe
joint swelling, pain, and histopathologic alterations than the lower dose.
It was observed that both standing and moving pain recovered over
time for both groups over 35 days while the joint structures continued
their deterioration. Most surprisingly, the standing pain was almost
completely alleviated by day 35 while the joints exhibited a strikingly
severe degeneration. To our knowledge, this is the ﬁrst report of such
temporally differential changes on pain and structural damage in MIA
induced rodent model. The results will shed light on the application
of rat MIA model in evaluating biologics and pharmaceuticals for OA
treatment.
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INFRAPATELLAR FAT PAD HYPERTROPHYWITHOUT INFLAMMATION IN
A DIET-INDUCED MOUSE MODEL OF OBESITY AND OSTEOARTHRITIS
W. Chang, J. DeMoe, C. Kent, S. Kovats, P. Garteiser, S. Doblas, R. Towner,
T.M. Grifﬁn. Oklahoma Med. Res. Fndn., Oklahoma City, OK, USA
Purpose: Obesity increases the risk of osteoarthritis (OA) at weight-
bearing and non-weight-bearing joints suggesting that a systemic factor
contributes to this risk. Obesity causes systemic low-grade inﬂammation
due in part to macrophage inﬁltration of hypertrophic visceral fat. Fat-
derived inﬂammatory mediators (i.e., adipokines) have been detected in
the synovial ﬂuid of the knee joint in patients with OA, although the
source of these adipokines is not known. The high risk of knee OA with
obesity suggests that the infrapatellar fat pad (IFP) may be a source
of local inﬂammation within the knee joint. In this study, we tested
the hypothesis that the IFP is a local source of inﬂammation in a diet-
induced obesity mouse model of OA. We compared changes in visceral,
subcutaneous, and IFP size, macrophage inﬁltration, and inﬂammatory
gene expression in mice fed a control or high-fat (HF) diet for 20 weeks.
Methods: Male C57BL/6J mice were fed either HF diet (60% fat, n = 10) or
control diet (10% fat, n = 10) for 20 weeks starting at 6 weeks of age. Fat
volumes were measured via water-suppressed MRI at 7T. Adipocyte size
was determined by H&E histomorphometry, and macrophage inﬁltration
was determined by immunoﬂuorescence using an F4/80 rat anti-
mouse puriﬁed monoclonal antibody (Invitrogen). Flow cytometry was
conducted on cells from the stromal vascular fraction of collagenase-
digested visceral and IFP using the antibodies CD45, F4/80, CD11c, and
CD206 (BioLegend) to identify immune cells, macrophages, inﬂammatory
macrophages, and regulatory macrophages, respectively. Inﬂammatory
cytokine and receptor gene expression was measured using the qPCR
array, PAMM-011D (SA Biosciences).
Results: High fat feeding signiﬁcantly increased visceral, subcutaneous,
and IFP volume by 463%, 298%, and 54%, respectively (p50%) but not in
the IFP (2-fold increase in expression in HF fed animals, including the
C-C motif chemokine Ccl2 which mediates macrophage adipose tissue
inﬁltration. However, only one chemokine was signiﬁcantly increased in
the IFP, Ccl17.
Conclusions: Here we show that visceral fat inﬂammation induced by
feeding mice a HF diet is not recapitulated in the IFP. Macrophage
inﬁltration of adipose tissue is typically associated with adipocyte
hypertrophy and death, and although HF feeding increases IFP volume,
the adipocytes in the IFP do not become hypertrophic. By responding
to a hyperlipidemic environment in a unique fashion that does not
involve increased lipid uptake and cell hypertrophy, IFP adipocytes
may be protected from obesity-induced macrophage inﬁltration and
inﬂammation. These ﬁndings suggest that the IFP is not a source of
macrophage-mediated inﬂammation in a diet-induced obese mouse
model of early onset knee OA.
Fig. 1. (A) Fat pad volumes from either control (white box) or high
fat (black box) mice were measured by MRI at 7 T. **p < 0.01, Student’s
t-test. (B) Macrophage inﬁltration was determined using F4/80 antibody
by immunoﬂuorescence imaging. *p < 0.05.
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SPONTANEOUS HEALING OF FIBROCARTILAGE AT THE INSERTION
OF ROTATOR CUFF AND ITS ENHANCEMENT BY TRANSOSSEOUS
PASSAGEWAY IN ANIMAL MODEL OF CYNOMOLGUS MONKEY
H. Ueba, S. Imai, S. Araki, H. Ishigaki, K. Nishizawa, T. Mimura,
K. Ogasawara, Y. Matsusue. Shiga Univ. of Med. Sci., Otsu, Japan
Purpose: It is well known that supraspinatus tendon has a prominent
zone of ﬁbrocatilage at its attachment site. And it is suggested that it
may have some important biomechanical role to protect the tendon.
Microfracture procedure represents a frequently used technique for
repairing of articular cartilage defects. With this procedure, marrow-
derived mesenchymal stem cells were led to produce a ﬁbrocartilage
repair at the defect site.
We compared healing process of the microfracture-group which had
microfracuture procedure after transection of the supraspinatus tendon
to the control group.
We chose cynomolgus monkeys as a model animal because they use
their forelimbs for grasping or holding things rather than walking unlike
other animals.
Methods: Eighteen cynomolgus monkeys were used in this study.
The shoulders were divided into 4 groups, which were determined by
the size of supraspinatus tear and subsequent microfractures: 4mm+,
4mm-, 8mm+, and 8mm-.
In the 4mm+ and 4mm− groups, the tendon was transected in 4mm
length. In the 8mm+ and 8mm− groups, the tendon was transected in
8mm length to be detached completely from its insertion. Microfracture
was then performed in the 4mm+ and 8mm+ groups.
The monkeys were euthanized on the 6, 12 and 24 weeks after surgery.
The specimens were evaluated with hematoxylin-eosin and and types I
and II collagen immunostaining.
Results: In all groups, torn sites were surrounded by granulation tissue.
Histological analysis revealed progressive maturation and reorganization
of the bone-tendon interface. Compared to the 4mm− group, more
collagen ﬁber continuity and more ﬁbrocartilage at the insertion site
was seen in the 4mm+ group. Same trend was seen in comparison the
8mm− group to the 8mm+ group.
